Cargando…
MicroRNA-217 Acts as a Tumor Suppressor and Correlates with the Chemoresistance of Cervical Carcinoma to Cisplatin [Retraction]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295451/ https://www.ncbi.nlm.nih.gov/pubmed/37384218 http://dx.doi.org/10.2147/OTT.S427141 |
Ejemplares similares
-
MicroRNA-217 acts as a tumor suppressor and correlates with the chemoresistance of cervical carcinoma to cisplatin
por: Yin, Zhaojun, et al.
Publicado: (2019) -
MicroRNA-217 Acts as a Tumor Suppressor and Correlates with the Chemoresistance of Cervical Carcinoma to Cisplatin [Expression of Concern]
Publicado: (2022) -
Retraction: The MicroRNA-217 Functions as a Potential Tumor Suppressor in Gastric Cancer by Targeting GPC5
Publicado: (2023) -
Retraction: MicroRNA-217 Regulates WASF3 Expression and Suppresses Tumor Growth and Metastasis in Osteosarcoma
Publicado: (2022) -
Retraction: MicroRNA-503 Acts as a Tumor Suppressor in Osteosarcoma by Targeting L1CAM
Publicado: (2022)